Despite recommendations and the passage of legislation, there is little evidence that the quality of behavioral health has improved significantly over the last 10 years in the United States.
Ten years ago the Institute of Medicine (IOM) issued a report that made bold recommendations to improve the quality of behavioral health care in the United States, but few of them have been implemented.
According to a recently published overview in the June 2016 issue of Health Affairs, even with the enactment of the Affordable Care Act (ACA), the passage of legislation in 2008 requiring parity of insurance coverage for behavioral and physical health, and greater recognition of the effect behavioral health disorders have on the population’s health, there is little evidence that the quality of behavioral health has improved significantly over the last 10 years. This is the case even though reforms have brought expanded resources and requirements for assessing quality, and provided an increased number of state and nongovernmental organizations charged with focusing on developing and implementing quality measures for behavioral health.
Harold Alan Pincus, MD, of the Department of Psychiatry, College of Physicians and Surgeons at Columbia University in New York City, and colleagues provided an overview of the current state of quality measurement in behavioral health, and make recommendations as to how to develop a set of measures for behavioral health quality that are as robust as those for general medical conditions.
For example, the authors wrote, the average performance on 4 behavioral health measures among commercial plans reported in 2014 was 48% compared with an average of 72% for 6 cardiovascular and diabetes measures. These findings meant that, on average, people with mental health or substance use needs get recommended care half the time, while recommended care occurs about two-thirds of the time for people with diabetes or hypertension. The patterns were the same in Medicare and Medicaid, research suggested.
The authors highlight the following 5 key priorities that need to be addressed:
The authors concluded that in order to move from measurement to improvement of behavioral healthcare, there must be national leadership and coordination in terms of what entities are responsible for supporting and funding the science of developing quality measurement and improvement strategies.
Stronger collaboration between funding agencies is needed. Data sources must be linked, including better adoption of electronic health records, which has lagged in behavioral health settings. Finally, a well-prepared workforce must be trained and held accountable for improving quality and outcomes for individuals with behavioral health conditions.
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More